Charles A. Reinhart III

Insider Reports History

Entity
Individual
Location
C/O Pacira Biosciences, Inc., 5401 West Kennedy Boulevard, Suite 890, Tampa, FL
Signature
/s/ Kristen Williams, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles A. Reinhart III:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pacira BioSciences, Inc. Chief Financial Officer Common Stock 51.9K $1.47M $28.38 Jun 12, 2024 Direct
Pacira BioSciences, Inc. Chief Financial Officer Stock Option (Right to Buy) 22.5K Jun 14, 2023 Direct

Insider Reports Filed by Charles A. Reinhart III

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCRX Pacira BioSciences, Inc. Jun 12, 2024 1 $0 4 Jun 13, 2024 Chief Financial Officer
PCRX Pacira BioSciences, Inc. Jun 3, 2024 1 -$92K 4 Jun 5, 2024 Chief Financial Officer
PCRX Pacira BioSciences, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Chief Financial Officer
PCRX Pacira BioSciences, Inc. Jun 6, 2023 2 -$100K 4 Jun 7, 2023 Chief Financial Officer
PCRX Pacira BioSciences, Inc. Jun 6, 2022 3 -$154K 4 Jun 8, 2022 Chief Financial Officer
PCRX Pacira BioSciences, Inc. Jun 9, 2021 2 $0 4 Jun 11, 2021 Chief Financial Officer
PCRX Pacira BioSciences, Inc. Jun 4, 2021 1 -$162K 4 Jun 8, 2021 Chief Financial Officer